Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Gas Purifier

By Drug Discovery Trends Editor | December 1, 2009

VICIGas purification is critical to GC performance and is essential in any application requiring extreme sensitivity. Several types of contaminants are detrimental – notably moisture, hydrocarbons, and oxygen. Contaminant traps and gas purifiers for specific gases dramatically reduce the levels of contaminants, enhance the purity of lower grade helium, and help insure instrument stability, reproducibility, and lower maintenance cost.

VICI Metronics’ Gas Purifiers are designed to be placed in-line with the GC carrier or detector gas supply to remove contaminants from the analytical gases prior to entering the GC.

These gas purifiers dramatically reduce contaminant levels and absorb a greater variety of contaminants than other gas purification products. Advanced materials and design features guarantee that the purifiers will produce gases that are at least a factor of ten higher than a 99.9999% “chromatography grade” cylinder of gas when the purifier is supplied by a 99.995% cylinder. The cost difference between the two grades of gas will pay for the cost of the gas purifier several times over during its operating life.

This product line includes OEM gas purifiers for the Agilent Mass Spec and LC Mass Spec. Metronics supplies purifiers for Helium, Hydrogen, Nitrogen, Methane, and Air, and offers traps for Moisture, Hydrocarbons, Oxygen, Sulfur, and Mercury.

VICI Metronics


Filed Under: Drug Discovery

 

Related Articles Read More >

S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
Drug companies sign “Most Favored Nation” deals, then raise prices anyway
New gonorrhea antibiotic could treat resistant infections
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE